These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 3402474

  • 1. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [Abstract] [Full Text] [Related]

  • 2. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [Abstract] [Full Text] [Related]

  • 3. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 4. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun 15; 142(12):1371-82. PubMed ID: 2190685
    [Abstract] [Full Text] [Related]

  • 5. Management of hyperlipidaemia.
    Sum CF, Tan CE, Chew LS.
    Singapore Med J; 1995 Aug 15; 36(4):410-6. PubMed ID: 8919159
    [Abstract] [Full Text] [Related]

  • 6. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C, European Consensus Panel on HDL-C.
    Curr Med Res Opin; 2004 Aug 15; 20(8):1253-68. PubMed ID: 15324528
    [Abstract] [Full Text] [Related]

  • 7. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 15; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 8. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 15; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 9. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

  • 10. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 10; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 11. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ, Guérin M, Bruckert E.
    Eur Heart J; 1998 Feb 10; 19 Suppl A():A24-30. PubMed ID: 9519339
    [Abstract] [Full Text] [Related]

  • 12. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000 Feb 10; 74(3):215-53. PubMed ID: 10918811
    [Abstract] [Full Text] [Related]

  • 13. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 10; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Dec 10; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 15. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 10; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 16. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S, Hjermann I.
    J Cardiovasc Risk; 2003 Apr 10; 10(2):129-35. PubMed ID: 12668910
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 10; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 18. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D, Nakagawa-Toyama Y, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Sandoval JC, Ohama T, Nishida M, Ishigami M, Yamashita S.
    Eur J Clin Invest; 2009 Aug 10; 39(8):689-98. PubMed ID: 19490064
    [Abstract] [Full Text] [Related]

  • 19. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
    Assmann G, Schulte H, Funke H, von Eckardstein A.
    Eur Heart J; 1998 Oct 10; 19 Suppl M():M8-14. PubMed ID: 9821011
    [Abstract] [Full Text] [Related]

  • 20. [Recommendations for secondary prevention of the clinical coronary cardiopathy].
    Rev Esp Cardiol; 1985 Oct 10; 38(1):14-20. PubMed ID: 2858911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.